Glyriva Respirator Solution 25 mcg/ml contains Glycopyrronium Bromide, a long-acting antimuscarinic bronchodilator formulated for inhalation via a nebulizer or respirator system. It is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. This formulation is especially suitable for patients who have difficulty using dry powder or metered-dose inhalers, ensuring effective drug delivery through nebulization.
Glyriva Respirator Solution provides sustained bronchodilation, helping to relieve airflow limitation, reduce breathlessness, and improve overall respiratory function during long-term COPD management.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Long-Acting Muscarinic Antagonist (LAMA)
Glycopyrronium Bromide acts by selectively inhibiting muscarinic M3 receptors located on airway smooth muscle. By blocking the action of acetylcholine, it prevents bronchoconstriction and promotes relaxation of bronchial smooth muscles, leading to prolonged airway dilation. This mechanism improves airflow and reduces respiratory effort.
Glycopyrronium has a rapid onset of bronchodilation and a long duration of action, making it suitable for regular maintenance therapy. Its quaternary ammonium structure limits systemic absorption, thereby minimizing systemic anticholinergic side effects when administered by inhalation.
Glyriva Respirator Solution 25 mcg/ml is indicated for:
Maintenance treatment of chronic obstructive pulmonary disease (COPD)
Long-term management of airflow obstruction
Relief of COPD-related symptoms such as dyspnea
The dosage should be determined by a physician based on disease severity and patient response. Glyriva Respirator Solution is administered via a nebulizer or respirator device according to medical advice. The solution is intended for inhalation only and must not be swallowed or injected. Proper device usage and hygiene are essential to ensure effective therapy.
Effective bronchodilation through nebulized delivery
Suitable for patients unable to use inhaler devices properly
Provides sustained relief from COPD symptoms
Improves lung function and breathing comfort
Minimal systemic side effects with inhalation use
Elderly patients: Generally well tolerated; no routine dose adjustment required
Renal impairment: Use with caution in severe renal dysfunction
Pregnancy and lactation: Use only if clearly needed and under medical supervision
Glyriva Respirator Solution is usually well tolerated. Some patients may experience:
Dry mouth
Cough or throat irritation
Headache
Nasopharyngitis
Serious anticholinergic effects are uncommon at recommended doses.
Not intended for the relief of acute bronchospasm
Use with caution in patients with narrow-angle glaucoma or urinary retention
Avoid contact with eyes
Regular assessment of respiratory status is recommended
Store below 30°C in a dry place. Protect from light. Keep the container tightly closed and out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet